Tci Wealth Advisors, Inc. Blueprint Medicines Corp Transaction History

Tci Wealth Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 19, 2022	BUY	$45.23 - $70.15 $5,246 - $8,137	116 New	116 $6,000
Q1 2022 Apr 29, 2022	SELL	$54.1 - $110.08 $5,896 - $11,998	-109 Closed	0 $0
Q3 2021 Oct 29, 2021	BUY	$80.98 - $109.47 $8,826 - $11,932	109 New	109 $11,000
Q2 2021 Aug 02, 2021	SELL	$82.78 - $101.0 $4,139 - $5,050	-50 Closed	0 $0
Q1 2021 Apr 29, 2021	BUY	$90.71 - $108.28 $4,535 - $5,414	50 New	50 $5,000

351

60.3M

2.25M

1.18M

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.4B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.